Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models

[1]  M. Oshimura,et al.  Gender Difference of Hepatic and Intestinal CYP3A4 in CYP3AHumanized Mice Generated by a Human Chromosome-engineering Technique. , 2017, Drug Metabolism Letters.

[2]  M. Oshimura,et al.  Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology , 2017, Scientific Reports.

[3]  M. Oshimura,et al.  CRISPR/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells , 2017, Scientific Reports.

[4]  M. Oshimura,et al.  Continuous long-term cytotoxicity monitoring in 3D spheroids of beetle luciferase-expressing hepatocytes by nondestructive bioluminescence measurement , 2017, BMC Biotechnology.

[5]  M. Oshimura,et al.  Correlation between luminescence intensity and cytotoxicity in cell-based cytotoxicity assay using luciferase. , 2017, Analytical biochemistry.

[6]  M. Oshimura,et al.  A kidney injury molecule‐1 (Kim‐1) gene reporter in a mouse artificial chromosome: the responsiveness to cisplatin toxicity in immortalized mouse kidney S3 cells , 2016, The journal of gene medicine.

[7]  M. Ikawa,et al.  CRISPR/Cas9 mediated genome editing in ES cells and its application for chimeric analysis in mice , 2016, Scientific Reports.

[8]  M. Oshimura,et al.  Effects of duration of electric pulse on in vitro development of cloned cat embryos with human artificial chromosome vector. , 2016, Reproduction in domestic animals = Zuchthygiene.

[9]  M. Oshimura,et al.  Evaluation of an Hprt-Luciferase Reporter Gene on a Mammalian Artificial Chromosome in Response to Cytotoxicity , 2016, Yonago acta medica.

[10]  N. Kouprina,et al.  Moving toward a higher efficiency of microcell-mediated chromosome transfer , 2016, Molecular Therapy. Methods & Clinical Development.

[11]  Lei S. Qi,et al.  CRISPR/Cas9 in Genome Editing and Beyond. , 2016, Annual review of biochemistry.

[12]  M. Oshimura,et al.  Highly Efficient Transfer of Chromosomes to a Broad Range of Target Cells Using Chinese Hamster Ovary Cells Expressing Murine Leukemia Virus-Derived Envelope Proteins , 2016, PloS one.

[13]  Adam P. Arkin,et al.  The Genome Project-Write , 2016, Science.

[14]  T. Toki,et al.  Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities. , 2016, Cell reports.

[15]  D. Satoh,et al.  Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model , 2016, Scientific Reports.

[16]  Fengtang Yang,et al.  Chromosome engineering in zygotes with CRISPR/Cas9 , 2016, Genesis.

[17]  M. Oshimura,et al.  Development of a Safeguard System Using an Episomal Mammalian Artificial Chromosome for Gene and Cell Therapy , 2015, Molecular therapy. Nucleic acids.

[18]  Liang Li,et al.  Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos , 2015, Scientific Reports.

[19]  G. Church,et al.  Supplementary Materials for Genome-wide inactivation of porcine endogenous retroviruses ( PERVs ) , 2015 .

[20]  M. Oshimura,et al.  Mouse embryonic stem cells with a multi-integrase mouse artificial chromosome for transchromosomic mouse generation , 2015, Transgenic Research.

[21]  Hans Clevers,et al.  Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.

[22]  Lasse Ebdrup Pedersen,et al.  Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway , 2015, Scientific Reports.

[23]  Takanori Kanai,et al.  Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids , 2015, Nature Medicine.

[24]  M. Oshimura,et al.  A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges , 2015, Chromosome Research.

[25]  M. Oshimura,et al.  A novel and stable mouse artificial chromosome vector. , 2014, ACS synthetic biology.

[26]  O. Ohara,et al.  Generating a transgenic mouse line stably expressing human MHC surface antigen from a HAC carrying multiple genomic BACs , 2014, Chromosoma.

[27]  M. Oshimura,et al.  A Novel System for Simultaneous or Sequential Integration of Multiple Gene-Loading Vectors into a Defined Site of a Human Artificial Chromosome , 2014, PloS one.

[28]  I. Cascorbi,et al.  Functional Gene Variants of CYP3A4 , 2014, Clinical pharmacology and therapeutics.

[29]  M. Oshimura,et al.  Down syndrome-associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies , 2014, Scientific Reports.

[30]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[31]  N. Shimizu,et al.  A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21 , 2014, Transgenic Research.

[32]  L. Macdonald,et al.  Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice , 2014, Proceedings of the National Academy of Sciences.

[33]  H. Masumoto,et al.  Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology , 2014, Expert opinion on drug delivery.

[34]  Anneliese O. Speak,et al.  Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery , 2014, Nature Biotechnology.

[35]  M. Oshimura,et al.  A Human Artificial Chromosome Recapitulates the Metabolism of Native Telomeres in Mammalian Cells , 2014, PloS one.

[36]  Jin-Soo Kim,et al.  Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.

[37]  Luke A. Gilbert,et al.  Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System , 2013, Cell.

[38]  M. Oshimura,et al.  Highly stable maintenance of a mouse artificial chromosome in human cells and mice. , 2013, Biochemical and biophysical research communications.

[39]  S. Miyano,et al.  The landscape of somatic mutations in Down syndrome–related myeloid disorders , 2013, Nature Genetics.

[40]  M. Oshimura,et al.  Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans. , 2013, Human molecular genetics.

[41]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[42]  Russ B Altman,et al.  PharmGKB summary: very important pharmacogene information for CYP3A5. , 2012, Pharmacogenetics and genomics.

[43]  R. Arceci,et al.  Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. , 2011, Blood.

[44]  V. Tybulewicz,et al.  Genomically humanized mice: technologies and promises , 2011, Nature Reviews Genetics.

[45]  M. Oshimura,et al.  A new chromosome 14-based human artificial chromosome (HAC) vector system for efficient transgene expression in human primary cells. , 2011, Biochemical and biophysical research communications.

[46]  M. Oshimura,et al.  Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors , 2011, PloS one.

[47]  M. Oshimura,et al.  Integration-free and stable expression of FVIII using a human artificial chromosome , 2011, Journal of Human Genetics.

[48]  E. Volpi,et al.  Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells. , 2011, Human molecular genetics.

[49]  M Eileen Dolan,et al.  Clinically relevant genetic variations in drug metabolizing enzymes. , 2011, Current drug metabolism.

[50]  Shigeyuki Yamaguchi,et al.  A Method for Producing Transgenic Cells Using a Multi-Integrase System on a Human Artificial Chromosome Vector , 2011, PloS one.

[51]  M. Oshimura,et al.  Identification of PITX1 as a TERT Suppressor Gene Located on Human Chromosome 5 , 2011, Molecular and Cellular Biology.

[52]  Jian-Kang Zhu,et al.  De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks , 2011, Proceedings of the National Academy of Sciences.

[53]  Y. Sakaki,et al.  Refined human artificial chromosome vectors for gene therapy and animal transgenesis , 2010, Gene Therapy.

[54]  M. Oshimura,et al.  Human Artificial Chromosome with a Conditional Centromere for Gene Delivery and Gene Expression , 2010, DNA research : an international journal for rapid publication of reports on genes and genomes.

[55]  M. Oshimura,et al.  Human chromosome 5 carries a transcriptional regulator of human telomerase reverse transcriptase (hTERT). , 2010, Biochemical and biophysical research communications.

[56]  M. Oshimura,et al.  Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer , 2010, BMC biotechnology.

[57]  N. Suzuki,et al.  Cell to cell transfer of the chromatin-packaged human β-globin gene cluster , 2009, Nucleic acids research.

[58]  S. Izraeli,et al.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. , 2009, Blood.

[59]  M. Oshimura,et al.  A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[60]  M. Oshimura,et al.  Introduction of a CD40L genomic fragment via a human artificial chromosome vector permits cell-type-specific gene expression and induces immunoglobulin secretion , 2008, Journal of Human Genetics.

[61]  John J Doyle,et al.  A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. , 2006, Blood.

[62]  M. Oshimura,et al.  Heat-regulated production and secretion of insulin from a human artificial chromosome vector. , 2006, Biochemical and biophysical research communications.

[63]  Y. Kajiwara,et al.  Monoallelic BUB1B mutations and defective mitotic‐spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome , 2006, American journal of medical genetics. Part A.

[64]  M. Oshimura,et al.  A Novel Human Artificial Chromosome Vector Provides Effective Cell Lineage–Specific Transgene Expression in Human Mesenchymal Stem Cells , 2005, Stem cells.

[65]  Dean Nizetic,et al.  An Aneuploid Mouse Strain Carrying Human Chromosome 21 with Down Syndrome Phenotypes , 2005, Science.

[66]  K. Meaburn,et al.  The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer , 2005, Chromosoma.

[67]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[68]  David J. Chen,et al.  Construction of a novel expression system on a human artificial chromosome. , 2005, Biochemical and Biophysical Research Communications - BBRC.

[69]  堀端 克良.  Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome , 2005 .

[70]  M. Oshimura,et al.  Construction of a novel human artificial chromosome vector for gene delivery. , 2004, Biochemical and biophysical research communications.

[71]  M. Oshimura,et al.  Dicer is essential for formation of the heterochromatin structure in vertebrate cells , 2004, Nature Cell Biology.

[72]  I. Ishida,et al.  Sequential targeting of the genes encoding immunoglobulin-μ and prion protein in cattle , 2004, Nature Genetics.

[73]  P. Vyas,et al.  Natural history of GATA1 mutations in Down syndrome. , 2004, Blood.

[74]  Alison Abbott,et al.  Laboratory animals: The Renaissance rat , 2004, Nature.

[75]  Y. Hayashi,et al.  Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. , 2003, Blood.

[76]  E. Fisher,et al.  Microcell-mediated chromosome transfer (MMCT): small cells with huge potential , 2003, Mammalian Genome.

[77]  B. Osborne,et al.  Cloned transchromosomic calves producing human immunoglobulin , 2002, Nature Biotechnology.

[78]  M. L. Beau,et al.  Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome , 2002, Nature Genetics.

[79]  E. Schuetz,et al.  Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. , 2002, Molecular pharmacology.

[80]  J. Azuma,et al.  Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population. , 2002, Pharmacogenetics.

[81]  D. Schindelhauer,et al.  Stable gene expression from a mammalian artificial chromosome , 2001, EMBO reports.

[82]  M. Oshimura,et al.  Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. , 2001, Human molecular genetics.

[83]  Ann Daly,et al.  Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression , 2001, Nature Genetics.

[84]  T. Hudson,et al.  A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. , 2001, American journal of human genetics.

[85]  M. Meguro,et al.  Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome. , 2000, Human molecular genetics.

[86]  Jennifer Nichols,et al.  A structurally defined mini-chromosome vector for the mouse germ line , 2000, Current Biology.

[87]  A. Feinberg,et al.  LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. , 1999, Human molecular genetics.

[88]  D. Hernandez,et al.  Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21. , 1999, Human molecular genetics.

[89]  M. Oshimura,et al.  Efficient modification of a human chromosome by telomere-directed truncation in high homologous recombination-proficient chicken DT40 cells. , 1998, Nucleic acids research.

[90]  Yusuke Nakamura,et al.  Positional cloning of the gene for Nijmegen breakage syndrome , 1998, Nature Genetics.

[91]  H. Masumoto,et al.  Construction of YAC–based mammalian artificial chromosomes , 1998, Nature Biotechnology.

[92]  M. Oshimura,et al.  Functional expression and germline atransmission of a human chromosome fragment in chimaeric mice , 1997, Nature Genetics.

[93]  M. Oshimura,et al.  Genetic mapping using microcell-mediated chromosome transfer suggests a locus for Nijmegen breakage syndrome at chromosome 8q21-24. , 1997, American journal of human genetics.

[94]  M. Oshimura,et al.  Multiple pathways to cellular senescence: role of telomerase repressors. , 1997, European journal of cancer.

[95]  M. Oshimura,et al.  Restoration of the cholesterol metabolism in 3T3 cell lines derived from the sphingomyelinosis mouse (spm/spm) by transfer of a human chromosome 18 , 1993, Human Genetics.

[96]  M. Ikawa,et al.  Genome Editing in Mouse Zygotes and Embryonic Stem Cells by Introducing SgRNA/Cas9 Expressing Plasmids. , 2017, Methods in molecular biology.

[97]  M. Oshimura,et al.  Recurrent micronucleation through cell cycle progression in the presence of microtubule inhibitors. , 2015, Cell structure and function.

[98]  宮本 憲一.  A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21 , 2014 .

[99]  飯田 雄一.  Bi-HAC vector system toward gene and cell therapy , 2014 .

[100]  S. Bates,et al.  Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy. , 2012, Discovery medicine.

[101]  阿部 智志.  Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering , 2010 .

[102]  Peter A Carr,et al.  Genome engineering , 2009, Nature Biotechnology.

[103]  F. Jirik,et al.  Generation of Transgenic Mice and Germline Transmission of a Mammalian Artificial Chromosome Introduced into Embryos by Pronuclear Microinjection , 2004, Chromosome Research.

[104]  M. Oshimura,et al.  Human monochromosome hybrid cell panel characterized by FISH in the JCRB/HSRRB , 2004, Chromosome Research.

[105]  Anne E Kwitek,et al.  Multifactorial genetics: Rat genetics: attachign physiology and pharmacology to the genome , 2002, Nature Reviews Genetics.

[106]  M. Meguro,et al.  Mouse A9 cells containing single human chromosomes for analysis of genomic imprinting. , 1999, DNA research : an international journal for rapid publication of reports on genes and genomes.

[107]  A. Feinberg,et al.  Erratum: LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids (Human Molecular Genetics (1999) 8 (1209-1217)) , 1999 .

[108]  F. Ruddle,et al.  Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.